How to Value a Startup for Angel Investment: A Founder's Guide

I once watched a founder ask for a $12 million pre-money valuation on a company that had zero revenue, two part-time developers, and a pitch deck held together by enthusiasm and Canva templates. The angel across the table didn't laugh. He just asked one question: "What number would make you feel like you got a fair deal, and what number would make me feel like I'm not an idiot?" That question is the whole game. Valuing a startup for angel investment isn't a math problem you solve — it's a negotiation you survive, and the founders who understand that raise faster and give away less equity.

Here's the thing: unlike a public company, a startup has no earnings multiple, no comparable stock price, no analyst coverage. You're pricing a promise. And in 2026, with seed rounds getting more disciplined and founders more informed, the gap between what a founder thinks their company is worth and what an angel will actually pay has never been wider. I've sat on both sides of that table — as a founder raising, and as an angel writing checks. This is what actually happens when the numbers hit the paper.

By the end of this, you'll know the real startup valuation methods angels use, how to defend a pre-money valuation without sounding delusional, what happens to your equity after dilution, and the due diligence questions that kill deals before they close.

Why startup valuation refuses to follow normal rules

A bakery sells for roughly the value of its ovens, its lease, and a multiple of its yearly profit. A startup with no profit, no ovens, and a lease it hasn't signed yet somehow gets valued at eight figures. Sound insane? It is. And there's a reason for it.

When I first started angel investing about six years ago, I made a classic mistake: I tried to build a discounted cash flow model for a pre-revenue SaaS company. I spent two weeks on it. The output was a valuation range so wide it was useless — somewhere between $400,000 and $40 million. I showed it to a more experienced investor. He laughed, gently, and said the model told him nothing except that I didn't understand what I was pricing.

What you're pricing at the angel stage isn't cash flow. It's the probability-weighted outcome of a bet. Most startups in an angel portfolio go to zero. A few return 10x. One, if you're lucky, returns 100x. The valuation has to reflect that brutal distribution, which is why angels anchor on a handful of signals rather than spreadsheets.

What angels are really buying

Strip away the jargon and an angel is buying four things:

• The team's ability to execute — have they shipped anything before, together?
• Evidence of market pull — not interest, but people paying or signing up without being begged
• The size of the prize — can this realistically become a $100M+ business, or is it a nice $3M lifestyle company?
• How much of the risk has already been retired — a working product beats a mockup, every time

Notice what's absent: your five-year revenue projection. I've never once made an investment decision based on a founder's year-five forecast, and I don't know an angel who has. Those numbers are theater. What matters is whether the next 12 months are believable.

The key takeaway here is uncomfortable but freeing: you don't need a perfect valuation model. You need a defensible story about why the risk you're asking an angel to take is smaller than it looks.

The core startup valuation methods angels actually use

There are five methods you'll encounter. Three of them are genuinely useful at the angel stage. Two are mostly noise dressed up as rigor.

The scorecard method (my default)

This is the workhorse. You take a baseline valuation for a typical startup in your region and sector, then adjust it up or down based on weighted factors. Team quality, market size, product maturity, competitive moat, and traction each get a score. The output is a range, not a number.

When I invested in a B2B logistics tool two years ago, the scorecard put the company at roughly $2.8M pre-money. The founder wanted $4.5M. We landed at $3.2M with a slightly larger option pool. That's how it usually goes — the method gives you a defensible anchor, and the negotiation does the rest.

The Berkus method

Developed by angel investor Dave Berkus, this one assigns value to five milestones: sound idea, prototype, quality team, strategic relationships, and product rollout or sales. Each milestone that's been hit adds a defined chunk to the pre-money. It caps out around $2–3M for most companies, which makes it a good fit for pre-revenue deals and a poor fit for anything with real traction.

The venture capital method

This works backward. You estimate the exit value, apply a required return multiple (angels typically want 10x to 30x on a single bet), and discount back to today. It produces a number that often shocks founders — because it's honest about how much return an angel needs to justify the risk. Use it to sanity-check your ask, not to set it.

The two methods I'd skip: comparable transactions (private deal data is thin and often stale) and pure DCF (meaningless pre-revenue). If a founder leads with a DCF model, I assume they've never raised before.

Method	Best for	Weakness
Scorecard	Pre-revenue to early traction, most angel deals	Subjective weighting
Berkus	Idea and prototype stage	Caps low, ignores traction
VC method	Sanity-checking an ambitious ask	Requires exit assumptions
Comparables	Mature sectors with visible deals	Data is scarce and old
DCF	Revenue-generating businesses	Useless pre-revenue

One insider trick that took me years to internalize: anchor on the round size you need, not the valuation you want. If you need $500K to hit your next milestone, and angels in your space typically take 15–25% at seed, the math points you to a pre-money somewhere between $1.5M and $2.8M. Founders who start from "what am I worth" almost always overreach. Founders who start from "what do I need to raise and what's a fair slice" land the round.

Pre-money vs post-money: the trap that eats your equity

This is where I've seen more founders get quietly robbed than anywhere else. And it's not a scam — it's just arithmetic that nobody explains clearly before you sign.

The pre-money valuation is what your company is worth before the new money comes in. The post-money valuation is pre-money plus the amount raised. Your dilution is calculated against the post-money. Sounds simple. The confusion costs people real ownership.

A worked example

Say you raise $500,000 at a $2M pre-money. Post-money is $2.5M. The new investor owns $500K ÷ $2.5M = 20%. You and your co-founders keep 80%, minus whatever the option pool takes.

Now say a founder tells the investor "I'll give you 20% for $500K" without specifying pre or post. If that 20% is calculated on a post-money basis, the pre-money is $2M. If someone miscalculates and treats it as pre-money, the investor ends up with a different slice entirely. I watched a founder lose an extra 4% of her company because of exactly this ambiguity in a term sheet. Four percent. On a company that later raised at $40M, that's real money.

The rule I now follow without exception: every term sheet conversation names pre-money and post-money explicitly, in writing, before anyone gets excited. If an investor resists that clarity, that's your answer about how the rest of the relationship will go.

And keep the option pool in mind. Investors often require a pool of 10–15% to be created before the round, which dilutes you, not them. That pool is real cost. Factor it in before you agree to a headline number.

Convertible notes, SAFEs, and the terms hidden in the fine print

Most angel rounds in 2026 don't use priced equity at all. They use convertible notes or SAFEs — instruments that convert to equity later, usually at your next priced round. They're faster and cheaper to paper, which is why everyone loves them. They also hide landmines.

The two terms that matter most:

1. The valuation cap — the maximum valuation at which the note converts. A low cap is generous to the investor; a high cap protects you.
2. The discount rate — a percentage off the next round's price, usually 15–25%, rewarding the early investor for taking more risk.

Here's the trap. If you stack five convertible notes with different caps and no coordination, your next priced round becomes a nightmare of math, and founders routinely discover they've promised away more than they thought. I've seen a company where the aggregate conversion wiped out nearly 40% of founder equity in one fell swoop — because nobody modeled it until the Series A was already in motion.

Should you use a SAFE or a note?

SAFEs are simpler and don't accrue interest, which is why they dominate early rounds now. Notes are more familiar to some angels and can include interest and maturity dates. Neither is inherently better. What matters is that you model the conversion before you sign. Build a simple cap table in a spreadsheet and run the math at your expected next-round valuation. If you can't explain your own dilution in one sentence, you don't understand your own deal.

If you're still pulling together the documents an angel will ask for, it's worth getting your foundation right first — a solid business plan that attracts investors does more for your valuation than any clever instrument.

Due diligence: what angels check before they wire the money

Founders think due diligence is a one-way street. It isn't. The best angels expect you to run diligence on them too — and the ones who get defensive about it are the ones you should walk away from.

What angels actually look for

On the investor side, the checklist is usually shorter than founders fear:

• Cap table cleanliness — who owns what, any weird side agreements, any founder who left with equity
• Incorporation and IP — is the company properly formed, and does it actually own its code and brand?
• Financial reality — bank statements, not projections. What's the real burn?
• Customer proof — can you name them, and will they take a reference call?
• Founder references — the informal calls that decide more deals than any document

On your side, ask the angel three questions before you accept their money: How many of your portfolio companies have you helped raise a follow-on round? What's your typical involvement after the wire? And can I talk to two founders you've backed? If they dodge any of those, that's data. I once turned down a check from an angel who couldn't name a single founder willing to vouch for him. Best decision I made that year.

For founders thinking about the long game — valuation today is only half the picture. Building personal financial resilience alongside your company matters just as much, and the principles in these personal finance tips for entrepreneurs apply whether your startup raises or not.

Putting it together: the valuation conversation you actually want to have

Here's my honest take, and I'll defend it: the "right" valuation is the one that gets you funded by the right people without crippling your next round. Not the highest number. The highest number you can defend has a nasty habit of becoming a down round twelve months later, and down rounds destroy founder morale and team confidence faster than almost anything else.

In my experience, founders who raise at a slightly conservative valuation and then over-deliver on their milestones end up far better off than those who squeeze every dollar of headline value and then miss. The market remembers. So do your investors.

Your next action, concretely: build a one-page cap table in a spreadsheet right now. Model three scenarios — a $1.5M, $2.5M, and $4M pre-money. Run the dilution at each, including the option pool and any convertible notes you're considering. Then ask yourself which number lets you sleep at night and still hit your milestones. That number is your ask. Bring it to the table with confidence, and let the negotiation do what negotiations do.

Because at the end of the day, valuation is a conversation about risk — and the founder who understands that wins the room.

Frequently Asked Questions

What's a typical pre-money valuation for an angel round?

It depends heavily on stage, sector, and geography, but most pre-revenue to early-traction angel rounds land somewhere between $1.5M and $4M pre-money. Companies with strong traction, a proven team, or a hot sector can push higher. There's no universal number — the scorecard and Berkus methods exist precisely because the range is so wide.

How much equity should I give away in my first angel round?

Most founders give up 10–25% in a seed or angel round. Going above 25% early is a red flag to future investors, because it signals you'll be over-diluted by the time you reach a Series A. Keep the option pool in mind too — it often adds another 10–15% of dilution that founders forget to count.

Is a convertible note better than a priced round for angel investment?

Convertible notes and SAFEs are faster and cheaper to paper, which makes them ideal for small, fast angel rounds. Priced rounds give everyone clarity on ownership from day one. The right choice depends on how much you're raising and how soon you expect a larger round. Just model the conversion before you sign — that's where most surprises hide.

Can I value a pre-revenue startup at all?

Yes, but not with traditional financial methods. Pre-revenue startups are valued using qualitative and milestone-based approaches like the Berkus method or the scorecard method, which weight team, market, and progress rather than earnings. The valuation is essentially a negotiated estimate of risk, not a calculated fact.

What should I check during angel investor due diligence?

Ask how many of their portfolio companies have raised follow-on rounds, what their typical post-investment involvement looks like, and whether you can speak with founders they've backed. A good angel welcomes these questions. One who dodges them is telling you something important about the relationship ahead.